Stay updated on Finerenone and Empagliflozin Combination in CKD Clinical Trial
Sign up to get notified when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.

Latest updates to the Finerenone and Empagliflozin Combination in CKD Clinical Trial page
- Check4 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a minor technical release with no visible change to the study record history content.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew study data sections have been added to the history, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and related document sections. The record now shows a 2026-03-27 return with Quality Control Review status (Has Not Concluded).SummaryDifference0.8%

- Check41 days agoChange DetectedFooter now shows Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check48 days agoChange DetectedLatest version adds a 'Results Submitted' entry (v3.4.3) and removes the 'No Results Posted' entry (v3.4.2) in the history log, signaling an update to the trial's results submission status.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the funding notice and the Revision: v3.4.1 entry from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Finerenone and Empagliflozin Combination in CKD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone and Empagliflozin Combination in CKD Clinical Trial page.